Emerging Cellular Therapies: T Cells and Beyond

Cellular therapies, including those based on T cells, are becoming approved options for clinicians treating a range of diseases. Cytotoxic T lymphocytes (CTLs) can be modified ex vivo to express receptors such as chimeric antigen receptors (CARs) or T cell receptors, allowing them to target tumour c...

Descripción completa

Detalles Bibliográficos
Autores principales: Todryk, Stephen, Jozwik, Agnieszka, de Havilland, Julian, Hester, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468692/
https://www.ncbi.nlm.nih.gov/pubmed/30917514
http://dx.doi.org/10.3390/cells8030284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468692/
https://www.ncbi.nlm.nih.gov/pubmed/30917514
http://dx.doi.org/10.3390/cells8030284

Ejemplares similares